Schaller Martin, Tan Jerry, Webster Guy
Dr. Schaller is with the Department of Dermatology at Eberhard Karls University Tuebingen in Tuebingen, Baden-Wuerttemberg, Germany.
Dr. Tan is with the Windsor Clinical Research Inc and the Department of Medicine at University of Western Ontario in Windsor, Ontario, Canada.
J Clin Aesthet Dermatol. 2022 Jul;15(7):E60-E62.
Rosacea is a chronic disease requiring long-term management. However, it is often treated according to package label instructions, which reflect the conditions of a Phase III study rather than a chronic disease. Furthermore, due to a lack of clinical data or guidelines on long-term treatment, many clinicians choose to discontinue treatment once success has been reached, rather than continuing with maintenance therapy. As experienced practicing dermatologists and investigators in the field, in this article we address the current evidence gaps in rosacea management and provide practical advice to clinicians on how optimal outcomes can be achieved and maintained in patients with rosacea in real-world practice, based on our own experience and the available clinical data.
酒渣鼻是一种需要长期管理的慢性疾病。然而,它通常是按照包装标签说明进行治疗的,这些说明反映的是III期研究的情况,而非慢性疾病的情况。此外,由于缺乏关于长期治疗的临床数据或指南,许多临床医生在病情好转后就选择停止治疗,而不是继续进行维持治疗。作为该领域经验丰富的执业皮肤科医生和研究人员,在本文中,我们将探讨酒渣鼻管理方面当前存在的证据空白,并根据我们自己的经验和现有的临床数据,为临床医生提供实用建议,说明在现实临床实践中如何实现并维持酒渣鼻患者的最佳治疗效果。